GlassScriptPhysician profile
Amal Masri
NPI 1508956715
$5,352.77
in general payments reported to CMS, 2019-2025
17 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $194 · 2021: $313 · 2022: $1,283 · 2023: $797 · 2024: $1,444 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520 · Travel and Lodging: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.60 |
| Travel and Lodging | $546.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,565.22 | 2019-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Convatec INC. | $1,083.42 | 2024 | |
| Aroa Biosurgery Incorporated | $879.21 | 2022-2024 | |
| Nevro Corp. | $275.51 | 2022 | |
| Organogenesis INC. | $274.54 | 2020-2025 | Apligraf |
| Paratek Pharmaceuticals, INC. | $240.64 | 2025 | Nuzyra |
| Stryker Corporation | $199.31 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $184.73 | 2022 | |
| Bioventus LLC | $141.54 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $135.05 | 2019 | |
| Southern Edge Orthopaedics, INC. | $111.41 | 2025 | |
| Grt US Holding, INC. | $90.27 | 2022 | |
| Medtronic Vascular, INC. | $71.49 | 2019 | |
| Novo Nordisk INC | $42.38 | 2022-2023 | Ozempic, Rybelsus |
| Zyla Life Sciences, INC. | $20.43 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $19.77 | 2019 | |
| Polarityte, INC. | $17.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amal Masri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.